Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

India Shifts 50,000 Troops to China Border

In a historic military move, India has moved at least 50,000…
Read more

Historic Heatwave To Hit Northwest, Along With A Plague Of “Voracious Grasshoppers”

Meteorologists are warning of the worst heatwave that the…
Read more

Pennsylvania Lifts COVID-19 Mask Order After More Than a Year

As of 12:01 a.m. on Monday, June 28, Pennsylvania's long-standing…
Read more